phenytoin has been researched along with antipyrine in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 63 (70.79) | 18.7374 |
1990's | 9 (10.11) | 18.2507 |
2000's | 11 (12.36) | 29.6817 |
2010's | 6 (6.74) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Caron, G; Ermondi, G | 1 |
Jolivette, LJ; Ward, KW | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Duncton, MA; Emerling, DE; Kelly, MG; Nguyen, MT; Vincent, F | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Akamatsu, M | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Bending, MR; Dollery, CT; Kahn, GC; Mucklow, JC | 1 |
Breckenridge, AM; Ohnhaus, EE; Park, BK | 1 |
Brown, L; Horning, MG; Kellaway, P; Lertratanangkoon, K; Nowlin, J; Zion, TE | 1 |
Bender, AD; Richey, DP | 1 |
Byrne, E; Frewin, DB; Hallpike, JF; Harman, AW | 1 |
Kampmann, JP; Lumholtz, BI; Mølholm Hansen, J; Siersbaek-Nielsen, K; Skovsted, L | 1 |
Belpaire, FM; Bogaert, MG; van Peer, AP | 3 |
Belpaire, F; Bogaert, M; Van Peer, A | 1 |
Inaba, T; Kalow, W | 1 |
Azarnoff, DL; Gugler, R | 1 |
Gibaldi, M | 1 |
Bill, P; Buchanan, N; Eyberg, C; Moodley, G | 1 |
Meredith, PA; Ullah, M; Whitling, B | 1 |
Reidenberg, MM | 1 |
Azarnoff, DL; Cohlmia, JB; Gugler, R; Huffman, DH; Shoeman, DW | 1 |
Petruch, F; Schüppel, RV | 2 |
Levy, G; Soda, DM | 1 |
Mützell, S | 1 |
Fujii, E; Hirayanagi, N; Teshirogi, T | 1 |
Humphries, TJ | 1 |
Elyas, AA; Patsalos, PN; Zakrzewska, JM | 1 |
Büchsel, R; Kohl, D; Kreiten, K; Matern, S; Wietholtz, H; Zysset, T | 1 |
Hansen, JM; Jørgensen, B; Kayser, L; Perrild, H; Poulsen, HE; Skovsted, L | 1 |
Dickinson, RG; Fowler, DW; Kluck, RM | 1 |
Barre, J; Cournot, A; Duche, JC; Duchier, J; Guinot, P; Tillement, JP | 1 |
Richens, A; Rimmer, EM | 1 |
Abramson, FP | 1 |
Bachmann, KA; Jahn, D; Schwartz, J; Yang, C | 1 |
Weissel, M | 1 |
Horikoshi, I; Kanamoto, I; Kodachi, M; Koizumi, T | 1 |
Shrewsbury, RP | 1 |
Hanano, M; Harashima, H; Iga, T; Sawada, Y; Sugiyama, Y | 1 |
Hanano, M; Iga, T; Sawada, Y; Sugiyama, Y | 1 |
Gugler, R; Jensen, JC | 1 |
Dyas, J; Evans, PJ; Peters, JR; Riad-Fahmy, D; Rimmer, E; Scanlon, MF; Thomas, JP; Tsanaclis, L; Walker, RF | 1 |
Hopkins, K; Houston, JB; Morselli, PL; Rowland, M; Shaw, PN; Thiercelin, JF | 1 |
Passananti, GT; Vessell, ES | 1 |
Estabrook, RW; Greim, H; Remmer, H; Schenkman, J | 1 |
Vesell, ES | 2 |
Evans, DA | 1 |
Oldendorf, WH | 1 |
Gajewska, M | 1 |
Sotaniemi, EA | 1 |
Petruch, F; Schüppel, RV; Steinhilber, G | 1 |
Altland, K; Goedee, HW | 1 |
Azarnoff, DL; Boulos, BM; Kauffman, RE; Shoeman, DW | 1 |
Pelkonen, RO; Puukka, M; Sotaniemi, EA | 1 |
Boxenbaum, H | 1 |
Chan, HL | 1 |
Christensen, LK; Hansen, JM; Hegedüs, L; Perrild, H; Simonsen, K; Skovsted, L | 1 |
Hedges, A; Makki, KA; Perucca, E; Richens, A; Ruprah, M; Wilson, JF | 1 |
Carruthers, SG; Freeman, DJ; Keown, PA; Laupacis, A; Stiller, CR | 1 |
Laidlaw, J; Makki, K; Monks, A; Oxley, J; Richens, A | 1 |
Chiba, K; Ishizaki, T; Nakazawa, Y; Tabuchi, T; Wagatsuma, T | 1 |
Breimer, DD; Buruma, OJ; de Wolff, FA; Ferrari, MD; Vermeij, P | 1 |
Fujioka, H; Tan, T | 1 |
Goldberg, DM | 1 |
Kalow, W | 1 |
Belpaire, FM; Bogaert, MG; Rosseel, MT; Van Peer, AP | 1 |
Kaste, M; Neuvonen, PJ; Tokola, RA | 1 |
McDevitt, DG; Riddell, JG; Salem, SA | 1 |
Bliesath, H; Hartmann, M; Huber, R; Radtke, HW; Steinijans, VW; Wurst, W; Zech, K | 1 |
Brøsen, K; Dalhoff, K; Flachs, H; Loft, S; Poulsen, HE; Ranek, L; Wantzin, P | 1 |
Bachmann, KA; Jauregui, L | 1 |
Fendrich, Z; Jindrová, O; Láznícek, M; Staud, F | 1 |
Allen, E; Reece, PA; Sedman, AJ; Tsanaclis, LM; Wroe, SJ | 1 |
Kokue, E; Saitoh, T; Shimoda, M | 1 |
ZAKHARIIA, EA; ZAPADNIUK, VI | 1 |
Hu, C; Hu, X; Qu, J; Yang, M; Yuan, F | 1 |
Hu, C; Li, YY; Nie, Y; Zhang, L | 1 |
15 review(s) available for phenytoin and antipyrine
Article | Year |
---|---|
[Modification of the action of drugs by inhibition of their metabolism].
Topics: Antipyrine; Barbiturates; Drug Interactions; Enzyme Induction; Enzyme Repression; Ethanol; gamma-Glutamyltransferase; Glucaric Acid; Humans; Nicotine; Pharmaceutical Preparations; Pharmacology; Phenytoin; Rifampin | 1979 |
Pharmacokinetic consequences of aging.
Topics: Adult; Aged; Aging; Aminopyrine; Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antipyrine; Barbiturates; Blood Proteins; Digoxin; Disease; Female; Humans; Intestinal Absorption; Kidney; Kinetics; Male; Middle Aged; Pharmaceutical Preparations; Phenytoin; Protein Binding; Rats | 1977 |
Genetic factors in hepatic drug oxidation.
Topics: Animals; Antipyrine; Cytochrome P-450 Enzyme System; Humans; Liver; Lymphocytes; Male; Mammals; Mixed Function Oxygenases; Models, Biological; Nortriptyline; Oxidation-Reduction; Pharmaceutical Preparations; Phenytoin; Rats | 1976 |
Drug protein binding and the nephrotic syndrome.
Topics: Antipyrine; Blood Proteins; Clofibrate; Diazepam; Half-Life; Humans; Kinetics; Nephrotic Syndrome; Pharmaceutical Preparations; Phenytoin; Prednisone; Protein Binding; Serum Albumin | 1976 |
Drug metabolism in uremia.
Topics: Acetohexamide; Animals; Antipyrine; Humans; Hydrolysis; Lipid Metabolism; Microsomes, Liver; Oxidation-Reduction; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Procainamide; Rats; Tolbutamide; Uremia; Vitamin D | 1975 |
Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.
Topics: Aminopyrine; Animals; Antipyrine; Cytochrome P-450 Enzyme System; Diazepam; Drug Interactions; Humans; Omeprazole; Phenytoin; Propranolol; Theophylline; Warfarin | 1991 |
[Modification of peripheral thyroid hormone metabolism by drugs].
Topics: Amiodarone; Antipyrine; Dexamethasone; Heparin; Humans; Phenobarbital; Phenytoin; Propranolol; Protein Binding; Rifampin; Thiouracil; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 1988 |
Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Topics: Animals; Antipyrine; Barbiturates; Biological Availability; Chlorpromazine; Diazepam; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Pentazocine; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Propranolol; Quinidine; Rats; Species Specificity; Tissue Distribution; Tolbutamide; Valproic Acid; Warfarin | 1985 |
Utility of clinical chemical determinations of drug concentrations in biological fluids.
Topics: Adult; Allopurinol; Antipyrine; Ataxia; Chemistry, Clinical; Chromatography, Gas; Coffee; Desipramine; Dicumarol; Drug Antagonism; Drug Synergism; Ethanol; Female; Fluorometry; Half-Life; Humans; Iatrogenic Disease; Male; Mental Disorders; Metabolism; Methods; Middle Aged; Morphine; Nortriptyline; Nystagmus, Pathologic; Pharmaceutical Preparations; Pharmacogenetics; Pharmacology; Phenobarbital; Phenylbutazone; Phenytoin; Pregnancy; Smoking; Spectrophotometry; Twins; Ultraviolet Rays | 1971 |
Recent progress in pharmacogenetics.
Topics: Adult; Aged; Alcohol Oxidoreductases; Antipyrine; Asian People; Child, Preschool; Cholinesterases; Cyanides; Dicumarol; Diseases in Twins; Drug Hypersensitivity; Erythrocytes; Favism; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Isoniazid; Liver; Male; Metabolism, Inborn Errors; Middle Aged; Pharmacogenetics; Phenylbutazone; Phenylthiourea; Phenytoin; Pregnancy; Primaquine; Twins; Warfarin | 1969 |
Recent progress in pharmacogenetics.
Topics: Adult; Antipyrine; Cyanides; Dicumarol; Erythrocytes; Ethnicity; Female; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Humans; Isoniazid; Male; Middle Aged; Mutation; Pharmacogenetics; Phenylbutazone; Phenylthiourea; Phenytoin; Pregnancy; Racial Groups; Taste; Twins | 1969 |
[Genetically dependent variability of drug effects].
Topics: Anemia, Hemolytic; Anesthesia, General; Anesthetics; Animals; Antipyrine; Apnea; Atropine; Body Temperature; Coumarins; Cyanosis; Deficiency Diseases; Dexamethasone; Dogs; Drug Tolerance; Enzymes; Female; Glucosephosphate Dehydrogenase; Humans; Intraocular Pressure; Isonicotinic Acids; Male; Meperidine; Mice; Oxyphenbutazone; Pharmacogenetics; Phenacetin; Phenylbutazone; Phenytoin; Proteins; Rabbits; Rats; Succinylcholine | 1970 |
The expanding role of microsomal enzyme induction, and its implications for clinical chemistry.
Topics: Acetaminophen; Alcoholism; Animals; Antipyrine; Aryl Hydrocarbon Hydroxylases; Electron Transport; Energy Intake; Enzyme Induction; Epilepsy; Female; Humans; Male; Microsomes, Liver; Pharmacology; Phenobarbital; Phenylbutazone; Phenytoin; Smoking; Tolbutamide; Warfarin | 1980 |
The Upjohn Award Lecture 1981/La Conférence Upjohn 1981. The metabolism of xenobiotics in different populations.
Topics: Antipyrine; Asian People; Biotransformation; Black People; Ethanol; Genetic Variation; Genetics, Population; Humans; Kinetics; Oxidoreductases; Pharmaceutical Preparations; Phenytoin; Racial Groups; White People | 1982 |
Lack of pantoprazole drug interactions in man.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Antipyrine; Benzimidazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 Enzyme System; Diazepam; Digoxin; Drug Interactions; Female; Humans; Liver; Longitudinal Studies; Male; Nifedipine; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides; Theophylline; Tissue Distribution; Warfarin | 1994 |
5 trial(s) available for phenytoin and antipyrine
Article | Year |
---|---|
Differential effect of continuous administration of beta-adrenoceptor antagonists on antipyrine and phenytoin clearance.
Topics: Adrenergic beta-Antagonists; Adult; Antipyrine; Atenolol; Humans; Male; Metoprolol; Phenytoin; Propranolol | 1989 |
Effect of Ginkgo biloba extract on microsomal enzyme induction.
Topics: Adult; Antipyrine; Enzyme Induction; Half-Life; Humans; Male; Microsomes, Liver; Phenytoin; Plant Extracts | 1989 |
Lack of pantoprazole drug interactions in man.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absorption; Antipyrine; Benzimidazoles; Contraceptives, Oral, Hormonal; Cross-Over Studies; Cytochrome P-450 Enzyme System; Diazepam; Digoxin; Drug Interactions; Female; Humans; Liver; Longitudinal Studies; Male; Nifedipine; Omeprazole; Pantoprazole; Phenytoin; Proton Pump Inhibitors; Sulfoxides; Theophylline; Tissue Distribution; Warfarin | 1994 |
Use of single sample clearance estimates of cytochrome P450 substrates to characterize human hepatic CYP status in vivo.
Topics: Administration, Oral; Adult; Antipyrine; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Ethosuximide; Humans; Liver; Lorazepam; Male; Oxidoreductases, N-Demethylating; Phenobarbital; Phenytoin; Quinidine; Rifampin; Smoking; Theophylline; Valproic Acid | 1993 |
Gabapentin does not affect antipyrine clearance.
Topics: Acetates; Adult; Amines; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antipyrine; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug Interactions; Gabapentin; gamma-Aminobutyric Acid; Half-Life; Humans; Male; Phenytoin; Saliva | 1999 |
70 other study(ies) available for phenytoin and antipyrine
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
Topics: Amidohydrolases; Carbamates; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Piperazines; Stereoisomerism; Structure-Activity Relationship | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Drug concentration in saliva.
Topics: Adolescent; Adult; Aged; Antipyrine; Chlorpropamide; Humans; Hydrogen-Ion Concentration; Male; Meperidine; Middle Aged; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Propranolol; Protein Binding; Saliva; Tolbutamide | 1978 |
Use of saliva in therapeutic drug monitoring.
Topics: Antipyrine; Caffeine; Ethosuximide; Gas Chromatography-Mass Spectrometry; Humans; Immunoenzyme Techniques; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Primidone; Saliva; Theophylline | 1977 |
Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic population.
Topics: Adult; Antipyrine; Barbiturates; Enzyme Induction; Epilepsy; Female; Half-Life; Humans; Male; Microsomes, Liver; Osteomalacia; Patient Compliance; Phenytoin; Risk; Saliva | 1979 |
Unaltered metabolism of phenytoin in thyroid disorders.
Topics: Adult; Aged; Antipyrine; Female; Half-Life; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Aged; Phenytoin; Thyroid Function Tests; Thyroxine | 1978 |
In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
Topics: Animals; Antipyrine; In Vitro Techniques; Kidney Failure, Chronic; Kinetics; Liver; Oxidation-Reduction; Phenylbutazone; Phenytoin; Rabbits | 1978 |
Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
Topics: Acute Kidney Injury; Animals; Antipyrine; Blood Proteins; Female; Half-Life; Phenylbutazone; Phenytoin; Protein Binding; Rabbits; Uranyl Nitrate; Urea | 1978 |
Drug distribution in renal failure.
Topics: Antipyrine; Clofibrate; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Nephrotic Syndrome; Pharmaceutical Preparations; Phenytoin; Protein Binding; Serum Albumin | 1977 |
The metabolism of phenobarbitone, phenytoin and antipyrine in Black patients.
Topics: Adult; Antipyrine; Black People; Drug Interactions; Half-Life; Humans; Phenobarbital; Phenytoin; South Africa | 1977 |
Letter: Antipyrine half life and clearance in clinical practice.
Topics: Adult; Antipyrine; Drug Interactions; Female; Half-Life; Humans; Male; Phenytoin | 1976 |
Pharmacokinetics of drugs in patients with the nephrotic syndrome.
Topics: Adult; Antipyrine; Blood Proteins; Body Weight; Clofibrate; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nephrotic Syndrome; Phenytoin; Protein Binding | 1975 |
[Effects of anticonvulsive treatment on drug elimination in man. Induction of liver hydroxylating enzyme system by diphenylhydantoin and carbamazepine].
Topics: Adult; Antipyrine; Bilirubin; Carbamazepine; Creatinine; Epilepsy; Female; Half-Life; Humans; Hydroxylation; Liver; Male; Middle Aged; Phenytoin; Time Factors; Trigeminal Neuralgia | 1975 |
Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
Topics: Animals; Antipyrine; Biotransformation; Depression, Chemical; Half-Life; Hydroxylation; Male; Oxidation-Reduction; Oxyphenbutazone; Pharmaceutical Preparations; Phenytoin; Rats; Sulfanilamides; Time Factors | 1975 |
Computed tomography of the brain, hepatotoxic drugs and high alcohol consumption in male alcoholic patients and a random sample from the general male population.
Topics: Adult; Aged; Alcoholism; Analgesics; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Antipyrine; Aspirin; Barbiturates; Benzodiazepines; Brain Damage, Chronic; Cerebral Cortex; Cerebral Ventricles; Cerebral Ventriculography; Chi-Square Distribution; Chlormethiazole; Dextropropoxyphene; Drug Combinations; Drug Interactions; Humans; Ibuprofen; Liver; Liver Function Tests; Male; Middle Aged; Observer Variation; Pancreatic Function Tests; Phenothiazines; Phenytoin; Risk Factors; Sulfamethizole; Sulfamethoxypyridazine; Tomography, X-Ray Computed | 1992 |
[The significance of serum gamma-glutamyl transpeptidase (gamma-GTP) elevation caused by antiepileptic drug(s). Using the antipyrine metabolic capacity as a parameter of microsomal enzyme activity].
Topics: Adolescent; Adult; Alanine Transaminase; Anticonvulsants; Antipyrine; Aspartate Aminotransferases; Child; Child, Preschool; Female; gamma-Glutamyltransferase; Humans; Male; Microsomes, Liver; Phenytoin | 1991 |
Dose dependent enzyme induction by oxcarbazepine?
Topics: Aged; Anticonvulsants; Antipyrine; Carbamazepine; Dose-Response Relationship, Drug; Enzyme Induction; Female; Humans; Liver; Male; Middle Aged; Oxcarbazepine; Phenytoin; Trigeminal Neuralgia | 1990 |
Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism.
Topics: Adolescent; Adult; Aged; Antipyrine; Caffeine; Carbamazepine; Cytochrome P-450 Enzyme System; Enzyme Induction; Epilepsy; Female; Half-Life; Humans; Hydrocortisone; Male; Middle Aged; Phenytoin; Valproic Acid | 1989 |
Maternofetal transfer of phenytoin, p-hydroxy-phenytoin and p-hydroxy-phenytoin-glucuronide in the perfused human placenta.
Topics: Animals; Antipyrine; Female; Humans; In Vitro Techniques; Male; Maternal-Fetal Exchange; Metabolic Clearance Rate; Perfusion; Phenytoin; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Solubility | 1989 |
Interaction between vigabatrin and phenytoin.
Topics: Adolescent; Adult; Aminocaproates; Anticonvulsants; Antipyrine; Blood Proteins; Drug Interactions; Female; Half-Life; Humans; Male; Middle Aged; Phenytoin; Protein Binding; Seizures; Vigabatrin | 1989 |
Parallel induction of plasma alpha 1-acid glycoprotein concentration and antipyrine clearance by drugs.
Topics: Animals; Antipyrine; Chromatography, Gas; Colorimetry; Cytochrome P-450 Enzyme System; Dogs; Dose-Response Relationship, Drug; Enzyme Activation; Liver; Male; Metabolic Clearance Rate; Orosomucoid; Phenobarbital; Phenytoin | 1989 |
The use of single sample clearance estimates to probe hepatic drug metabolism in rats. I.
Topics: Animals; Antipyrine; Liver; Male; Metabolic Clearance Rate; Mixed Function Oxygenases; Models, Biological; Pharmaceutical Preparations; Phenytoin; Rats; Rats, Inbred Strains; Theophylline; Valproic Acid; Warfarin | 1988 |
[Effect of saikokeishi-to on the pharmacokinetics of phenytoin in rabbit].
Topics: Animals; Antipyrine; Drugs, Chinese Herbal; Male; Models, Biological; Phenytoin; Protein Binding; Rabbits | 1988 |
Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
Topics: Animals; Antipyrine; Blood Substitutes; Drug Combinations; Fluorocarbons; Hemodilution; Hydroxyethyl Starch Derivatives; Indocyanine Green; Kinetics; Liver; Pharmaceutical Preparations; Phenytoin; Propranolol; Rats | 1987 |
Prediction of serum concentration time course of quinidine in human using a physiologically based pharmacokinetic model developed from the rat.
Topics: Animals; Antipyrine; Half-Life; Hexobarbital; Humans; Kidney; Kinetics; Liver; Metabolic Clearance Rate; Models, Biological; Phenytoin; Quinidine; Rats; Time Factors | 1986 |
Interaction between metronidazole and drugs eliminated by oxidative metabolism.
Topics: Administration, Oral; Adult; Antipyrine; Chromatography, Gas; Diazepam; Drug Interactions; Female; Half-Life; Humans; Infusions, Parenteral; Kinetics; Male; Metronidazole; Phenytoin | 1985 |
Anticonvulsant therapy and cortisol elimination.
Topics: Adult; Anticonvulsants; Antipyrine; Dexamethasone; Female; Humans; Hydrocortisone; Male; Metabolic Clearance Rate; Middle Aged; Phenytoin; Saliva | 1985 |
Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.
Topics: Adult; Antipyrine; Biotransformation; Carbamazepine; Drug Interactions; Half-Life; Humans; Kinetics; Male; Phenytoin; Saliva | 1985 |
Editorial: Drug metabolism in disease.
Topics: Alanine Transaminase; Anti-Bacterial Agents; Antipyrine; Half-Life; Humans; Kidney; Kidney Diseases; Liver; Liver Diseases; Nortriptyline; Pharmaceutical Preparations; Phenytoin | 1974 |
Reaction of drugs with microsomal liver hydroxylase: its influence on drug action.
Topics: Aniline Compounds; Animals; Antipyrine; Benzopyrenes; Cytochromes; Dicumarol; Electron Transport; Enzyme Induction; Hexobarbital; Kinetics; Liver; Methylcholanthrene; Microsomes; Mixed Function Oxygenases; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Protein Binding; Prothrombin Time | 1968 |
The hydroxylation of drugs- a pharmacogenetic problem?
Topics: Antipyrine; Dicumarol; Endoplasmic Reticulum; Liver; Mixed Function Oxygenases; Nortriptyline; Pharmacogenetics; Phenylbutazone; Phenytoin | 1970 |
[Enhanced drug hydroxylation in man under diphenyl-hydantoin therapy].
Topics: Administration, Oral; Antipyrine; Biodegradation, Environmental; Creatinine; Epilepsy; Epilepsy, Tonic-Clonic; Half-Life; Humans; Hydroxylation; Liver; Male; Microsomes, Liver; Phenytoin; Stimulation, Chemical | 1974 |
Brain uptake of metabolites and drugs following carotid arterial injections.
Topics: Acetates; Amino Acids; Animals; Antipyrine; Ascorbic Acid; Aspirin; Barbiturates; Blood-Brain Barrier; Brain; Caffeine; Chloroquine; Cyanides; Ethanol; Imipramine; Lactates; Mescaline; Morphine; Neurotransmitter Agents; Nicotine; Penicillin G; Pharmaceutical Preparations; Phenytoin; Procaine; Pyruvates; Rats | 1971 |
Complexometric determination of various diazole derivatives with cupric picrate.
Topics: Aminopyrine; Antipyrine; Azoles; Copper; Histamine; Hydrogen-Ion Concentration; Imidazoles; Indicators and Reagents; Methods; Metronidazole; Phenylbutazone; Phenytoin; Picrates; Structure-Activity Relationship; Tolazoline | 1972 |
Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
Topics: Animals; Antipyrine; Brain; Brain Chemistry; Drug Interactions; Enzyme Induction; Half-Life; Kinetics; Liver; Male; Phenobarbital; Phenytoin; Proadifen; Rats; Time Factors | 1973 |
Effect of diphenylhydantoin on hepatic drug hydroxylation.
Topics: Adult; Antipyrine; Bilirubin; Colorimetry; Creatinine; Epilepsy; Half-Life; Humans; Hydroxylation; Jaundice; Liver; Male; Middle Aged; Pharmaceutical Preparations; Phenelzine; Phenytoin | 1974 |
Placental transfer of diphenylhydantoin in the goat.
Topics: Amniotic Fluid; Animals; Antipyrine; Blood Chemical Analysis; Blood Proteins; Chromatography, Gas; Electrophoresis; Female; Fetus; Gestational Age; Goats; Maternal-Fetal Exchange; Phenytoin; Pregnancy; Pregnancy, Animal | 1972 |
In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in uraemic rabbits.
Topics: Animals; Antipyrine; Female; In Vitro Techniques; Kinetics; Liver; Microsomes, Liver; Oxidation-Reduction; Phenylbutazone; Phenytoin; Rabbits; Uremia | 1980 |
Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays.
Topics: Adult; Aged; Antipyrine; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Glucaric Acid; Hepatitis; Histamine H1 Antagonists; Humans; Liver; Liver Cirrhosis; Male; Medroxyprogesterone; Middle Aged; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Prednisolone; Rifampin | 1980 |
Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.
Topics: Animals; Anti-Anxiety Agents; Antipyrine; Benzodiazepines; Cattle; Dogs; Goats; Guinea Pigs; Haplorhini; Humans; Liver; Liver Circulation; Mice; Organ Size; Phenytoin; Rabbits; Rats; Sheep; Species Specificity; Swine | 1980 |
Observations on drug-induced toxic epidermal necrolysis in Singapore.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antipyrine; Barbiturates; Burns; Child; Diagnosis, Differential; Drug Eruptions; Female; Humans; Male; Middle Aged; Necrosis; Penicillamine; Phenytoin; Syndrome; Tetracycline | 1984 |
Lack of stimulation of antipyrine and phenytoin metabolism by lithium carbonate in man.
Topics: Adult; Aged; Antipyrine; Drug Interactions; Female; Half-Life; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Mixed Function Oxygenases; Phenytoin | 1983 |
A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.
Topics: Anticonvulsants; Antipyrine; Carbamazepine; Enzyme Induction; Epilepsy; Female; Glucaric Acid; Half-Life; Humans; Immunoenzyme Techniques; Male; Microsomes, Liver; Phenobarbital; Phenytoin; Primidone; Valproic Acid | 1984 |
Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites.
Topics: Adult; Antipyrine; Biotransformation; Chromatography, High Pressure Liquid; Cyclosporins; Drug Interactions; Half-Life; Humans; Male; Phenytoin; Radioimmunoassay | 1984 |
Effects of sodium valproate on the serum protein binding of phenytoin, and on liver enzyme activity.
Topics: Antipyrine; Aspartate Aminotransferases; Blood Proteins; Glucaric Acid; Half-Life; Humans; Liver; Phenytoin; Protein Binding; Time Factors; Valproic Acid | 1980 |
Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy.
Topics: Adult; Anticonvulsants; Antipyrine; Delivery, Obstetric; Dose-Response Relationship, Drug; Epilepsy; Female; Half-Life; Humans; Infant, Newborn; Metabolic Clearance Rate; Phenobarbital; Phenytoin; Postpartum Period; Pregnancy; Pregnancy Complications; Time Factors; Valproic Acid | 1982 |
Impairment of phenytoin parahydroxylation as a cause of severe intoxication.
Topics: Aged; Antipyrine; Debrisoquin; Humans; Hydroxylation; Kinetics; Male; Phenytoin | 1983 |
Biopharmaceutical studies on hydantoin derivatives. III. Physico-chemical properties, dissolution behavior, and bioavailability of the molecular compound of 1-benzenesulfonyl-5,5-diphenylhydantoin and antipyrine.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Biological Availability; Chemical Phenomena; Chemistry; Dogs; Drug Combinations; Intestinal Absorption; Male; Phenytoin; Solubility | 1982 |
Distribution of antipyrine, phenylbutazone and phenytoin in experimental renal failure.
Topics: Acute Kidney Injury; Animals; Antipyrine; Blood Proteins; Female; Phenylbutazone; Phenytoin; Protein Binding; Rabbits; Tissue Distribution | 1981 |
Binding of drugs in serum, blood cells and tissues of rabbits with experimental acute renal failure.
Topics: Acute Kidney Injury; Animals; Antipyrine; Blood Cells; Blood Proteins; Female; Phenylbutazone; Phenytoin; Protein Binding; Rabbits; Tissue Distribution | 1981 |
Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test.
Topics: Adult; Aged; Antipyrine; Cimetidine; Drug Interactions; Female; Guanidines; Humans; Kinetics; Male; Middle Aged; Phenytoin; Prospective Studies | 1981 |
Interaction between phenytoin and dichloralphenazone [proceedings].
Topics: Aged; Antipyrine; Chloral Hydrate; Drug Interactions; Female; Half-Life; Humans; Phenytoin | 1980 |
Drug metabolism and genetic polymorphism in subjects with previous halothane hepatitis.
Topics: Adult; Aged; Antipyrine; Chemical and Drug Induced Liver Injury; Complement C3; Female; Halothane; HLA Antigens; Humans; Male; Mephenytoin; Metronidazole; Middle Aged; Phenotype; Phenytoin; Polymorphism, Genetic; Sparteine | 1993 |
Phenytoin transfer across the in situ perfused rat term placenta.
Topics: Analgesics; Animals; Anticonvulsants; Antipyrine; Blood Proteins; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Female; Perfusion; Phenytoin; Placenta; Pregnancy; Protein Binding; Rats; Rats, Wistar | 1997 |
The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits.
Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antipyrine; Area Under Curve; Chromatography, High Pressure Liquid; Escherichia coli; Female; Half-Life; Injections, Intramuscular; Interleukin-6; Lipopolysaccharides; Metabolic Clearance Rate; Nifedipine; Phenytoin; Protein Binding; Rabbits; Theophylline; Vasodilator Agents | 2000 |
[THE REPRODUCTION OF AUDIOGENIC CONVULSIONS AFTER THE PRELIMINARY ADMINISTRATION OF PYRAMIDONE TO ANIMALS].
Topics: Acetazolamide; Aminopyrine; Anticonvulsants; Antipyrine; Epilepsy, Reflex; Mice; Pharmacology; Phenobarbital; Phenytoin; Primidone; Rats; Research; Seizures; Sound; Toxicology | 1964 |
Degradation of selected pharmaceuticals in aqueous solution with UV and UV/H(2)O(2).
Topics: Antipyrine; Biodegradation, Environmental; Diphenhydramine; Hydrogen Peroxide; Ibuprofen; Kinetics; Oxidation-Reduction; Pesticide Residues; Phenytoin; Photochemistry; Photolysis; Spectrophotometry, Ultraviolet; Water Pollutants, Chemical | 2009 |
Enhanced Fenton-like degradation of refractory organic compounds by surface complex formation of LaFeO(3) and H(2)O(2).
Topics: 2,4-Dichlorophenoxyacetic Acid; Acyclovir; Antipyrine; Catalysis; Chlorophenols; Hydrogen Peroxide; Oxides; Phenytoin; Sulfamethoxazole; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2015 |